| ExpressionEdits Ltd.. (5/29/24). "Press Release: ExpressionEdits Raises $13M in Seed Funding to Advance Protein Expression Using AI-Driven Intronization Technology". Cambridge. |
2024-05-29 |
| Adcendo ApS. (5/29/24). "Press Release: Adcendo ApS Announces Extension of Series A Financing to EUR 98M to Further Bolster its First-in-Class ADC Pipeline". Copenhagen. |
2024-05-29 |
| Merck & Co., Inc.. (5/29/24). "Press Release: Merck to Acquire EyeBio". Rahway, NJ & New York, NY. |
2024-05-29 |
| Merck KGaA. (5/29/24). "Press Release: Merck Signs MoU with KAIST to Advance Scientific Collaboration". Darmstadt. |
2024-05-29 |
| Fresenius SE & Co. KGaA. (5/29/24). "Press Release: Fresenius Appoints Internationally Experienced Biopharma Expert to the Fresenius Kabi Management Board". |
2024-05-29 |
| Cargo Therapeutics, Inc.. (5/28/24). "Press Release: Cargo Therapeutics to Participate in Upcoming Investor Conferences". San Carlos, CA. |
2024-05-28 |
| Numab Therapeutics AG. (5/28/24). "Press Release: Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis". H |
2024-05-28 |
| Asahi Kasei Corporation. (5/28/24). "Press Release: Asahi Kasei to Acquire Calliditas Therapeutics AB to Accelerate Growth as a Global Healthcare Company". |
2024-05-28 |
| Hitachi High-Tech Corporation. (5/27/24). "Press Release: Roche and Hitachi High-Tech Extend Their Long-standing Partnership". Tokyo. |
2024-05-27 |
| Orna Therapeutics, Inc.. (5/23/24). "Press Release: Orna Therapeutics Announces Strategic Acquisition of ReNAgade Therapeutics to Solidify Leadership in Circular RNA Therapies". Watertown, MA & Cambridge, MA. |
2024-05-23 |
| Radar Therapeutics Inc.. (5/23/24). "Press Release: Radar Therapeutics Raises $13.4M in Seed Funding to Develop Smart Programmable Medicines Using Molecular RNA Sensors". Berkeley, CA. |
2024-05-23 |
| Deepull Diagnostics S.L.. (5/22/24). "Press Release: Deepull Appoints Didier Deltort to Its Board of Directors". Barcelona. |
2024-05-22 |
| Daiichi Sankyo Co., Ltd.. (5/22/24). "Press Release: Daiichi Sankyo Establishes Two Research Institutes in the U.S. and EU". |
2024-05-22 |
| En Carta Diaganostics. (5/22/24). "Press Release: En Carta Diagnostics Secures €1.5m in Pre-seed Funding to Advance Diagnostic Kit Platform for Lyme disease". Paris. |
2024-05-22 |
| Jeito Capital. (5/22/24). "Press Release: Jeito Capital Announces Acquisition of Portfolio Company HI-Bio by Biogen Inc. (Nasdaq: BIIB) for up to $1.8 Billion". Paris. |
2024-05-22 |
| Meatable. (5/22/24). "Press Release: Meatable Appoints U.S.-based Meat industry Veteran Jeff Tripician as New CEO". Leiden. |
2024-05-22 |
| Refeyn Ltd.. (5/22/24). "Press Release: Refeyn Announces Appointment of Fiona Coats as Chief Marketing Officer". Oxford. |
2024-05-22 |
| SixPeaks Bio AG. (5/22/24). "Press Release: SixPeaks Bio AG Debuts With $110 Million in Funding". Basel. |
2024-05-22 |
| Merck KGaA. (5/22/24). "Press Release: Merck Signs Definitive Agreement to Acquire Life Science Company Mirus Bio for US$ 600 million". Darmstadt. |
2024-05-22 |
| Biogen Inc.. (5/22/24). "Press Release: Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences". Cambridge, MA & South San Francisco, CA. |
2024-05-22 |
| Boehringer Ingelheim. (5/22/24). "Press Release: Boehringer Ingelheim and OSE Immunotherapeutics Expand Collaboration to Develop First-in-class Treatments for Cancer and Cardio-renal-metabolic Diseases". Ingelheim & Nantes. |
2024-05-22 |
| Pheon Therapeutics Ltd.. (5/21/24). "Press Release: Pheon Therapeutics Announces $120m Series B Financing to Fund Development of Its Differentiated ADC Pipeline". London. |
2024-05-21 |
| Limula SA. (5/21/24). "Press Release: Limula Raises CHF 6.2 Million in Oversubscribed Seed Round to Develop Automated Cell and Gene Therapy Manufacturing Platform". Lausanne. |
2024-05-21 |
| Scion Instruments. (5/21/24). "Press Release: SCION Instruments Has a New CEO". |
2024-05-21 |
| Cellugy. (5/21/24). "Press Release: Danish Industrial Biotechnology Startup Cellugy Raises €4.9M to Replace Petrochemicals in Personal Care Products". Søborg. |
2024-05-21 |
| Forbion Capital Partners. (5/21/24). "Press Release: Forbion Leads $65 Million Series A Financing of Progentos Therapeutics". Naarden. |
2024-05-21 |
| Cutiss AG. (5/17/24). "Press Release: Cutiss Announces First Closing of CHF 25M in Series C Funding Round". Switzerland. |
2024-05-17 |
| Accelerated Biosciences Corporation. (5/16/24). "Press Release: Accelerated Biosciences and Spanios Partner to Advance Therapeutic Design Across Solid Tumor Cancers". Houston, TX. |
2024-05-16 |
| Sartorius AG. (5/16/24). "Press Release: Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with Nvidia". Göttingen. |
2024-05-16 |
| Bremen, Senatskanzlei. (5/16/24). "Pressemitteilung: Massenspektrometrie aus Bremen – Bruker Daltonics erweitert Produktion mit zweitem Standort in der Hansestadt". Bremen. |
2024-05-16 |
| Single Use Support GmbH. (5/15/24). "Press Release: Novo Holdings Acquires Majority Stake in Single Use Support". Kufstein. |
2024-05-15 |
| Molecular Health GmbH. (5/15/24). "Press Release: Integrated DNA Technologies and Molecular Health Ink Commercial Partnership". Coralville, IA & Heidelberg. |
2024-05-15 |
| NeoSphere Biotechnologies GmbH. (5/14/24). "Press Release: NeoSphere Biotechnologies Partners with Kymera Therapeutics for Novel Molecular Glue Target Discovery". Martinsried. |
2024-05-14 |
| Sartorius AG. (5/13/24). "Press Release: Sartorius Collaborates with Sanofi to Commercialize End-to-end Platform for Downstream process intensification". Göttingen. |
2024-05-13 |
| AC Immune S.A.. (5/13/24). "Press Release: AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease". Osaka, Cambride, MA & Lausanne. |
2024-05-13 |
| ERS Genomics Ltd.. (5/13/24). "Press Release: ERS Genomics Appoints John E Milad as Chief Executive Officer". Stockholm. |
2024-05-13 |
| Lycia Therapeutics, Inc.. (5/13/24). "Press Release: Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracellular Protein Degraders to the Clinic". South San Francisco, CA. |
2024-05-13 |
| Ajax Therapeutics, Inc.. (5/13/24). "Press Release: Ajax Therapeutics Raises $95 Million Series C Financing To Advance First-in-Class Type II JAK2 Inhibitor, AJ1-11095, Into The Clinic". New York, NY & Cambridge, MA. |
2024-05-13 |
| Allogene Therapeutics, Inc.. (5/13/24). "Press Release: Allogene Therapeutics Announces Pricing of $110 Million Offering of Common Stock". South San Francisco, CA. |
2024-05-13 |
| iTeos Therapeutics Inc.. (5/10/24). "Press Release: iTeos Therapeutics Announces $120 Million Registered Direct Offering". Watertown, MY & Gosselies. |
2024-05-10 |
| Genespire S.r.l.. (5/9/24). "Press Release: Genespire Presents Positive Preclinical Proof of Concept Data at the ASGCT Annual Meeting". Milan. |
2024-05-09 |
| Bar-Ilan University. (5/7/24). "Press Release: Opmed.ai Raises $15M". |
2024-05-07 |
| Memo Therapeutics AG. (5/7/24). "Press Release: Memo Therapeutics Increases Series C Financing to CHF 45 Million". Schlieren. |
2024-05-07 |
| Cache DNA, Inc.. (5/7/24). "Press Release: Cache Raises Seed Financing to Advance its Biomolecule Storage Technologies". San Carlos, CA. |
2024-05-07 |
| Insempra GmbH. (5/7/24). "Press Release: Insempra Completes $20 Million Financing to Advance the Development of Next-generation Bio-based Ingredients". Munich. |
2024-05-07 |
| ADC Therapeutics S.A.. (5/6/24). "Press Release: ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants". Lausanne. |
2024-05-06 |
| Topas Therapeutics GmbH. (5/6/24). "Press Release: Topas Therapeutics Appoints Hugo Fry as CEO". Hamburg. |
2024-05-06 |
| WhiteLab Genomics. (5/6/24). "Press Release: WhiteLab Genomics Establishes US Presence by Securing Spot at Bayer Co.Lab and Ginkgo Bioworks’ Technology Network". Cambridge, MA. |
2024-05-06 |
| Eisbach Bio GmbH. (5/6/24). "Press Release: Eisbach Bio Announces FDA Clearance of IND Application for EIS-12656, a First-in-Class Allosteric Inhibitor of ALC1". Martinsried. |
2024-05-06 |
| Wacker Chemie AG. (5/6/24). "Press Release: Wacker Expands Production Capacity for Biopharmaceuticals in San Diego". Munich & San Diego, CA. |
2024-05-06 |
| Latus Bio, Inc.. (5/2/24). "Press Release: Latus Launches with State-of-the-Art Gene Therapy Development Technologies, Two Lead Product Candidates, and an Initial $54 Million in Series A Financing". Philadeliphia, PA. |
2024-05-02 |
| Mariana Oncology Inc.. (5/2/24). "Press Release: Mariana Oncology to Be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer". Watertown, MA. |
2024-05-02 |
| Kurma Partners. (5/2/24). "Press Release: Kurma Partners Announces the Promotion of Hadrien Bouchez to the Position of Partner". Paris. |
2024-05-02 |
| Karius, Inc.. (5/2/24). "Press Release: Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare". Redwood City, CA. |
2024-05-02 |
| Accelerated Biosciences Corporation. (5/2/24). "Press Release: Mekonos Enters Partnership Agreement with Accelerated Biosciences to Develop and Commercialize Engineered Human Trophoblast Stem Cells (hTSCs) for Biomanufacturing". Alameda, CA. |
2024-05-02 |
| Novartis AG. (5/2/24). "Press Release: Novartis Enters Agreement to Acquire Mariana Oncology, Strengthening Radioligand Therapy Pipeline". Basel. |
2024-05-02 |
| Sphere Fluidics Ltd.. (4/30/24). "Press Release: Sphere Fluidics Appoints Dale Levitzke as Chief Executive Officer". Cambridge. |
2024-04-30 |
| Avacta Group plc. (4/30/24). "Press Release: Christina Coughlin, MD, PhD, appointed Chief Executive Officer of Avacta Group". |
2024-04-30 |
| Locate Bio Ltd.. (4/29/24). "Press Release: Locate Bio Raises £9.2 Million to Progress LDGraft Clinical Study for Anterior Lumbar Interbody Fusion". Nottingham. |
2024-04-29 |
| Addex Therapeutics S.A.. (4/29/24). "Press Release: Addex Provides Update on ADX71149 Phase 2 Epilepsy Study". Geneva. |
2024-04-29 |
| Miltenyi Biotec B.V. & Co. KG. (4/29/24). "Press Release: Miltenyi Biotec and MiLaboratories Announce Strategic Partnership to Advance Next-generation Therapies". Bergisch Gladbach & San Francisco, CA. |
2024-04-29 |
| General Inception. (4/29/24). "Press Release: General Inception Launches Igniter Europe with the Support of Leading Institutions and Venture Capital Firms". Palo Alto, CA & Lyon. |
2024-04-29 |
| Pfizer Inc.. (4/26/24). "Press Release: U.S. FDA Approves Pfizer’s Beqvez (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B". New York, NY. |
2024-04-26 |
| Basel Area Business & Innovation. (4/26/24). "Press Release: Johnson & Johnson Opens Innovation Hub in Allschwil". |
2024-04-26 |
| Variantyx, Inc.. (4/26/24). "Press Release: Variantyx Secures $36M Investment as Testing Demand and Market Share Continues to Increase". Framingham, MA. |
2024-04-26 |
| Merck KGaA. (4/25/24). "Press Release: Merck Invests More Than € 300 Million in New Life Science Research Center in Germany". Darmstadt. |
2024-04-25 |
| Cosmo Pharmaceuticals N.V.. (4/25/24). "Press Release (Ad hoc): Cosmo Announces Leadership Changes. Giovanni Di Napoli Appointed as New CEO Effective from 24 May 2024.". Dublin. |
2024-04-25 |
| PinkDx, Inc.. (4/25/24). "Press Release: PinkDx Launches with $40 Million Series A Financing to Develop Diagnostics Addressing Unmet Medical Needs for Women". Daly City, CA. |
2024-04-25 |
| CureVac N.V.. (4/24/24). "Press Release: CureVac Appoints Thaminda Ramanayake as New Chief Business Officer". Tübingen & Boston, MA. |
2024-04-24 |
| Artiva Biotherapeutics, Inc.. (4/24/24). "Press Release: Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer |
2024-04-24 |
| Seamless Therapeutics GmbH. (4/23/24). "Press Release: Seamless Therapeutics Announces New CEO and Board Chairman to Support US Expansion of Programmable Recombinase Gene Editing Technology Platform". Dresden & Lexington, MA. |
2024-04-23 |
| High-Tech Gründerfonds Management GmbH. (4/23/24). "Press Release: Cultimate Foods Raises 2.3 Million EUR Seed Funding from Leading Biotech and Foodtech Investors to Revolutionize the Alternative Meat Industry". Berlin. |
2024-04-23 |
| Evotec SE. (4/23/24). "Press Release: Evotec SE Appoints Dr Christian Wojczewski as Chief Executive Officer". Hamburg. |
2024-04-23 |
| Smart Reporting GmbH. (4/22/24). "Press Release: Smart Reporting Successfully Closes Financing Round for 23 Million Euros". Munich. |
2024-04-22 |
| Deepull Diagnostics S.L.. (4/18/24). "Press Release: Deepull Appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing and Sales Officer". Barcelona. |
2024-04-18 |
| Outrun Therapeutics Ltd.. (4/18/24). "Press Release: Outrun Therapeutics Launches with a $10m Seed Financing from M Ventures and MP Healthcare Venture Management to Develop a Protein Stabilisation Pipeline". Dundee. |
2024-04-18 |
| Evotec SE. (4/18/24). "Press Release: Evotec and Variant Bio Enter Strategic Partnership to Discover and Develop Fibrosis Treatments". Hamburg & Seattle, WA. |
2024-04-18 |
| NanoString Technologies, Inc.. (4/17/24). "Press Release: NanoString Technologies to Be Acquired by Bruker Corporation. Bruker Wins Competitive Auction". Seattle, WA. |
2024-04-17 |
| Canaan Partners. (4/17/24). "Press Release: Canaan Adds Accomplished Executive and Scientist, Uwe Schoenbeck, Ph.D., Along with New Capital, to Bolster its Biopharma Investment Efforts". Menlo Park, CA. |
2024-04-17 |
| Evotec SE. (4/17/24). "Press Release: Evotec Welcomes Aurélie Dalbiez as Chief People Officer". Hamburg. |
2024-04-17 |
| Domain Therapeutics S.A.. (4/17/24). "Press Release: Domain Therapeutics Appoints Sean A. MacDonald as Chief Executive Officer". Strasbourg, Motnreal, QC & Boston, MA. |
2024-04-17 |
| Theolytics Ltd.. (4/17/24). "Press Release: Theolytics Successfully Closes Latest Financing Raising Total of £19M ($24.5M) and Welcomes Sound Bioventures as New Investor". Oxford. |
2024-04-17 |
| CureVac N.V.. (4/16/24). "Press Release: CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines". Tübingen & Houston, TX. |
2024-04-16 |
| Etherna N.V.. (4/16/24). "Press Release: Shelly West Joins Etherna as Business Development Director US". Niel. |
2024-04-16 |
| Recursion Pharmaceuticals, Inc.. (4/16/24). "Press Release: Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer". Salt Lake City, UT. |
2024-04-16 |
| MedinCell S.A.. (4/16/24). "Press Release: Medincell Enters into Strategic Co-development and Licensing Agreement with AbbVie to Develop Next-generation Long-acting Injectable Therapies". Montpellier. |
2024-04-16 |
| KBI Biopharma, Inc.. (4/15/24). "Press Release: KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer". Durham, NC. |
2024-04-15 |
| Naobios. (4/15/24). "Press Release: Naobios and Sumagen Sign Exclusive Partnership to Develop HIV Vaccine". Nantes. |
2024-04-15 |
| DeepCure, Inc.. (4/11/24). "Press Release: DeepCure Closes $24M Funding Round Led by IAG Capital Partners". Boston, MA. |
2024-04-11 |
| Idorsia Ltd.. (4/11/24). "Press Release: Idorsia Takes Steps to Address Short-term Liquidity Needs". Allschwil. |
2024-04-11 |
| Roche. (4/11/24). "Press Release: Roche Granted FDA Breakthrough Device Designation for Blood Test to Support Earlier Alzheimer's Disease Diagnosis". Basel. |
2024-04-11 |
| FundaMental Pharma GmbH. (4/11/24). "Press Release: FundaMental Pharma Appoints Dr. Dirk Beher as Chief Executive Officer". Heidelberg. |
2024-04-11 |
| Vertex Pharmaceuticals Inc.. (4/10/24). "Press Release: Vertex Enters into Agreement to Acquire Alpine Immune Sciences". Boston, MA & Seattle, WA. |
2024-04-10 |
| Adrenomed AG. (4/10/24). "Press Release: AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock". Hennigsdorf. |
2024-04-10 |
| TORL BioTherapeutics, LLC. (4/10/24). "Press Release: TORL BioTherapeutics Announces $158 Million Oversubscribed Series B-2 Financing to Advance the Clinical Development of its Novel Antibody-Drug Conjugate (ADC) Oncology Pipeline". Los Angeles, CA. |
2024-04-10 |
| Orgenesis Inc.. (4/10/24). "Press Release: Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility". Ormond Beach, FL & Germantown, |
2024-04-10 |
| CRS Clinical Research Services Management GmbH. (4/10/24). "Press Release: CRS Appoints Catherine Canales as New Chief Commercial Officer to Fuel Strategic Development and International Growth". Mannheim. |
2024-04-10 |
| Seaport Therapeutics. (4/9/24). "Press Release: Seaport Therapeutics Launches with $100 Million Oversubscribed Series A Financing Round to Advance Novel Neuropsychiatric Medicines". Boston, MA. |
2024-04-09 |
| Nvelop Therapeutics. (4/9/24). "Press Release: Nvelop Therapeutics Launches with Dual Platforms for In Vivo Delivery of the Next Generation of Genetic Medicines". Cambridge, MA. |
2024-04-09 |
| Boehringer Ingelheim. (4/9/24). "Press Release: Boehringer Ingelheim Biopharmaceuticals China Receives Approval for Supply of EU and US Markets". Ingelheim & Shanghai. |
2024-04-09 |
![[LSUS] Life-Sciences-USA.com - The Transatlantic Life Sciences Web Portal](/images/basics/lsus-life-sciences-usa-portal-logo.svg){kind=logo}
1 2 3 4 ... 51 52 53 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
